Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04408443Not ApplicableTerminated

Evaluation of Lactobacillus Reuteri DSM 17938 + Vitamin D3 in the Prevention of RRI in Paediatric Patients

Role: lead

NCT02945683Not ApplicableCompleted

Effects of Lactobacillus Reuteri Plus Vitamin D3 in Children With Atopic Dermatitis

Role: lead

NCT05684848Not ApplicableUnknown

Evaluate the Effect of Nasal Spray in the Prevention of RTI in Children With Pre-school Wheezing

Role: lead

NCT03857360Not ApplicableCompleted

Effectiveness of PENTABIOCEL in Clinical and Laboratory Recovery of Children With Celiac Disease

Role: collaborator

All 4 trials loaded